To hear about similar clinical trials, please enter your email below
Trial Title:
Comparison of the Complications in Multiple Myeloma Patients Who Received Autologous Stem Cell Transplantation Between in HEPA-filtered Room and Non-HEPA-filtered Room
NCT ID:
NCT06286241
Condition:
Multiple Myeloma
Conditions: Official terms:
Multiple Myeloma
Neoplasms, Plasma Cell
Conditions: Keywords:
multiple myeloma
autologous stem cell transplantation
HEPA-filtered room
non-HEPA-filtered room
Study type:
Observational [Patient Registry]
Overall status:
Not yet recruiting
Study design:
Time perspective:
Other
Summary:
The goal of this observational study is to comparison of the complications in multiple
myeloma patients who received autologous stem cell transplantation between in
HEPA-filtered room and non-HEPA-filtered room. The main questions it aims to answer are:
- The incidence of febrile neutropenia, infection, and duration of hospital stay
- 2-year progression free survival Participants will be collected the data of baseline
diagnosis, treatment, treatment results and complications during admission and
follow-up visits from hospital medical record.
Criteria for eligibility:
Study pop:
multiple myeloma patients who received autologous stem cell transplantation
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- aged 18 - 65 years old
- Patients with multiple myeloma undergoing treatment with autologous stem cell
transplantation and having a Hematopoietic Cell Transplantation-Specific Comorbidity
Index (HCT-CI) score less than or equal to 2
- Patients must provide signed consent to participate in the research if they undergo
ASCT after the study has been approved.
- If patients undergo ASCT before the study approval, retrospective data will be
collected.
Exclusion Criteria:
- Patients with concomitant other types of cancer
- Patients who refuse to participate in the study.
Gender:
All
Minimum age:
18 Years
Maximum age:
65 Years
Healthy volunteers:
No
Start date:
March 25, 2024
Completion date:
July 30, 2024
Lead sponsor:
Agency:
Siriraj Hospital
Agency class:
Other
Collaborator:
Agency:
Faculty of Medicine Siriraj Hospital
Agency class:
Other
Source:
Siriraj Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06286241
